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Abstract 
Invasive lobular cancer (ILC) tends to be significantly larger in size with significantly more 
positive lymph nodes, whereas ILC has a significantly more favorable outcome, compared to 
stage-matched invasive ductal carcinoma (IDC). The mechanism accounting for such differ-
ences remains elusive. Based on morphological, immunohistochemical, and molecular studies 
of over 1,000 cases of human breast cancers, we hypothesize that the differences may result 
from the structural and/or functional differences of their surrounding myoepithelial cell layers, 
which dictate lobular and ductal tumor cells to follow different pathways of invasion or me-
tastasis. The background, rationale, supportive data, and implications of our hypothesis are 
presented and discussed. 
Key words: Invasive lobular cancer, invasive ductal carcinoma, human breast cancers, myoepithe-
lial cell layers 
Introduction 
It has been well documented and generally ac-
cepted that ILC tend to be significantly larger in size 
with  a  significantly  higher  rate  of  positive  lymph 
nodes than its stage-matched ductal counterpart [1-3]. 
Although large tumor size and positive lymph node 
are two well-recognized risk factors for worse prog-
nosis,  patients  with  ILC  have  a  substantially  more 
favorable clinical outcome compared to patients with 
IDC  [1-5].  These  contradictory  impacts  have  been 
largely attributed to the unique biological features of 
ILC,  including  the  lack  of  E-cadherin  expression, 
higher expression of ER and PR, lower expression of 
HER-2,  p53,  and  EGFR,  and  lower  S-phase  fraction 
[6-9]. The trigger factor for the significant differences 
in biological behavior and clinical outcomes between 
ILC and IDC, however, have not been identified 
Based on our previous morphological, immuno-
histochemical,  and  molecular  studies  of  over  1,000 
cases of human breast cancers, we speculate that the 
substantial  difference  in  clinical  outcomes  between 
ILC  and  IDC  may  results  from  the  structural  and 
functional  differences  of  their  surrounding  myoepi-
thelial cell layers, which control the genetic property 
and  biological  behavior  of  the  pre-invasive  lesions Int. J. Biol. Sci. 2011, 7 
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and dictate lobular and ductal tumors to follow dif-
ferent pathways for invasion and/or metastasis. Our 
speculation  is  consistent  with  a  number  of  experi-
mental findings and clinical reports.  
1. Structural differences in the myoepithelial cell 
layer between the lobular and ductal systems 
The epithelial cells of normal lobular and ductal 
systems are surrounded by the basement membrane 
and  a  layer  of  myoepithelial  cells.  The  basement 
membrane  is  structurally  similar  in  both,  but  the 
myoepithelial cell layer in the ductal system generally 
forms a ring-like structure completely surrounding all 
epithelial cells. In contrast, the myoepithelial cell layer 
in the lobular system is often discontinuous (defined 
as the lack of direct physical contact among adjacent 
myoepithelial  cells  or  the  presence  of  small  gaps, 
generally smaller than the size of one myoepithelial 
cell) in some (<20%) lobular clusters [10-12] (Fig 1). 
2. Functional differences in the myoepithelial cell 
layer between the lobular and ductal systems 
 The myoepithelial cell layer is the sole source of 
a  number  of  tumor  suppressors,  including  maspin, 
p63, and Wilms’ tumor 1 (WT-1), which display sig-
nificant  inhibition  on  proliferation  and  invasion  of 
associated tumor cells [13-18]. In the normal ductal 
system, tumor suppressors are consistently expressed 
in all or nearly all morphologically identifiable my-
oepithelial cells [15-17]. In contrast, a subset of mor-
phologically distinct myoepithelial cells in the lobular 
system are often devoid of expression of tumor sup-
pressors [19,20] (Fig 2). In some cases, the lack of tu-
mor suppressor p63 expression in myoepithelial cells 
was correlated with cytoplasmic p63 expression in the 
associated epithelial cells, which show increased ag-
gressiveness and invasiveness [17, 20] (Fig 2c-2d).  
 
Fig 1. Structural variations in myoepithelial cell layer between the lobular and ductal systems. Normal human 
breast tissue sections were immunostained with a myoepithelial cell marker, smooth muscle actin (SMA; red) and a 
basement membrane marker, collagen IV (brown). Thick arrows identify the basement membrane. Thin arrows identify 
myoepithelial cell layers. Note that the myoepithelial cell layer is more distinct in the duct than in the lobular system. 150X.  
 
Fig 2. Differential expression of tumor suppressors in myoepithelial cell layers of the lobular and ductal 
systems. Human breast tissue sections were immunostained for tumor suppressor p63. Circles identify lobules with no or 
cytoplasmic p63 expression. Arrows in a-c identify normal p63 expression in ducts. Arrow in D shows myoepithelial cell 
lacking p63. 200X. 
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In  addition,  the  myoepithelial  cell  layer  in  the 
entire lobule of some cases show signs of degenerative 
changes, including a significantly lower frequency of 
proliferation  and  expression  of  tumor  suppressors 
and  other  phenotypic  markers,  whereas  a  signifi-
cantly  higher  frequency  of  apoptosis,  focal  disrup-
tions and leukocyte infiltration [21-24]. Pre-invasive 
breast  tumors  with  aberrant  expression  of  tumor 
suppressors  in  the  myoepithelial  cell  layers  had  a 
significantly  higher  proliferation,  genetic  and  bio-
chemical  abnormalities  than  their  morphologically 
similar counterparts with normal expression of these 
tumor suppressors [25-30] (Fig 3). 
3. Correlation between the status of myoepi-
thelail cell layers and biological presentations of 
tumor cells 
The status of the myoepithelial cell layer appears 
to correlate with the biological presentation of associ-
ated epithelial cells. A number of cell surface adhesion 
molecules,  including  E-cadherin,  are  strongly  ex-
pressed in nearly all ductal cells and their malignant 
derivatives,  but  are  absent  in  their  lobular  counter-
parts [31,32] (Fig 4). 
 
Fig 3. Higher proliferation index in tumors with aberrant expression of tumor suppressors in myoepithelial 
cell layers. Human breast tumor sections were double immunostained for tumor suppressor WT-1 (red) and a cell pro-
liferation marker, Ki-67 (brown). Thick arrows identify myoepithelial cell layers with and without WT-1 expression. Thin 
arrows identify proliferating cells. Arrowhead identifies WT-1 positive endothelial cells, which serve as internal controls to 
indicate that the loss of WT-1 staining in the myoepithelial cells is not an artifact. 200X.  
 
Fig 4. Differential expression of cell surface adhesion molecule E-cadherin in lobular and ductal cells. Human 
breast tissue sections were double immunostained for SMA (red) and E-cadherin (black). Arrows identify myoepithelial cell 
layers in normal (a), hyperplastic (b), and pre-invasive (c) lobular lesions. Circles identify E-cadherin positive ductal cells. 
Note that the lobular cells are devoid of E-cadherin expression, while their associated ductal cells are strongly positive. 
150X.  
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In the lobular system, elevated cell proliferation 
or malignancy-associated changes are often simulta-
neously  present  at  the  entire  lobular  structures  of 
morphologically normal appearing lobules, in which 
all  tumor  cells  share  a  similar  morphological  and 
immunohistochemical profile with adjacent invasive 
lesions  [23,24]  (Fig  5a-5d).  In  contrast,  elevated  cell 
proliferation and malignancy-associated changes are 
only seen at or near focally disrupted myoepithelial 
cell layers (defined as a gap larger than the combined 
size of at least 3-myepithelial cells in at least 3 con-
secutive sections), in which the “budding” tumor cells 
are  morphologically  and  immunohisto-chemically 
distinct  from  their  adjacent  counterparts  within  the 
tumor core [ 25-30] (Fig 5e-5h). 
 
 
Fig 5. Comparison of the growth pattern and molecular profiles in potential precursors of invasive lesions. 
Human breast tissue sections were double immunostained for different markers. Circles identify potential precursors of 
invasive lesions (asterisks). Note that malignancy-associated changes are seen at multiple or the entire lobular elements, 
while are only present at or near focally disrupted myoepithelial cell layers with different profiles in the ductal system. 200X.  
 
Similar  alterations  and  focal  disruptions  have 
been detected in the human prostate basal cell layer, 
which is structurally equivalent to the breast myoep-
ithelial cell layer [33-38]. Similarly, aberrant expres-
sion of tumor suppressors and focal disruptions on 
the basal cell layer have the same impact on the asso-
ciated prostate tumor cells [33-38]. 
Our hypothesis 
Based on the above findings and the following 
facts: [1] the epithelial component of the human breast 
consists of acinar cells that are mainly for the milk 
production,  and  duct  cells,  which  are  mainly  for 
providing the drainage for the secretions, [2] lobular 
buds derive from terminal ducts during breast mor-
phogenesis, and [3] normal, hyperplastic, and in situ 
neoplastic  lobular  cells  can  be  distinguished  from 
ductal  cells  by  morphology  and  expression  of 
E-cadherin, we propose that the structural and func-
tional  difference  in  their  surrounding  myoepithelial 
cell layers may represent a trigger factor accounting 
for  the  substantial  difference  in  clinical  outcomes 
between ILC and IDC. We define lobular cells as aci-
nar  or  secretory  cells  that  are  mainly  for  the  milk 
production. Consequently, we refer lobular carcinoma 
as cancers consisting of malignant acinar or secretory 
cells.  
Alterations in the myoepithelial cell layer may 
directly impact the clinical outcomes of ILC and IDC 
by  controlling  the  genetic  property  and  biological 
behavior of the precursors of invasive lesions, and by 
dictating the lobular and ductal tumors to follow dif-
ferent pathways for invasion and/or metastasis. More 
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specifically,  the  less  consistent  expression  of  tumor 
suppressors in the myoepithelial cell layer of the lob-
ular  system  would  permit  extensive  proliferation, 
differentiation, molecular and biochemical changes at 
the  productive  age,  especially  during  pregnancy, 
which could exhaust or “use up” the residual stem 
cells. Consistent with this speculation is the fact that a 
number  of  case-control  studies  have  consistently 
shown that long-standing lactation and reproductive 
parameters  could  significantly  reduce  breast  cancer 
risk [39-40].  
In  addition,  as  aberrant  expression  of  tumor 
suppressors with malignancy-associated changes are 
exclusively  seen  in  some  acinar  clusters  or  lobules 
[23,24],  degradation  of  the  myoepithelial  cell  layers 
could  potentially  lead  to  in situ  malignant  transfor-
mation of the entire tumor cell population within a 
given  lobule  to  invasive  lesions.  Therefore,  lobular 
lesions may be at greater risk to develop invasion and 
metastasis  to  lymph  node.  This  speculation  is  con-
sistent with a case control study of 37,692 ductal car-
cinoma in situ (DCIS) and 4,490 lobular carcinoma in 
situ  (LCIS),  which  showed  that  patients  with  LCIS 
were 5.3-fold more likely than patients with DCIS to 
develop  invasive  lobular  lesions  [41].  Due  to  the 
above reasons, invasive and metastatic lobular lesions 
may have lower potential to initiate new tumor nests 
in new sites. Consistent with this speculation is the 
fact  that  only  the  tumor  cells  expressing  stem  cell 
markers could significantly contribute to carcinogen-
esis  and  tumor  progression,  or  to  significant  tumor 
growth in animal models [42-43].  
In sharp contrast, as the epithelial component is 
normally devoid of blood vessels and lymphatic ducts 
and totally depends on the stroma for its metabolic 
needs  and  even  survival,  a  focal  myoepithelial  cell 
layer disruption in a given duct could have a number 
of consequences, including: (a) a localized loss or re-
duction of tumor suppressors and the paracrine in-
hibitory functions, which allow the associated tumor 
cells to undergo elevated proliferation [44-46], (b) fo-
cal alterations in the permeability for oxygen, which 
selectively triggers the exit of stem or progenitor cells 
from  quiescence  [47-48],  (c)  a  localized  increase  of 
leukocyte  infiltration,  which  directly  export  growth 
factors to the associated epithelial cells through direct 
physical  contact  [49-53],  (d)  the  direct  epitheli-
al-stromal  cell  contact,  which  augments  the  expres-
sion of stromal MMP or represses the normal produc-
tion and distribution of E-cadherin and other cell ad-
hesion molecules, facilitating epithelial-mesenchymal 
transition and cell motility [54-56], (e) the direct ex-
posure  of  the  epithelial  cells  to  different  cytokines, 
which  stimulate  an  aberrant  expression  of  c-erbB2, 
which  facilitates  vasculogenic  mimicry  and  tumor 
angiogenesis [57-58], and (f) the direct physical con-
tact between newly formed cell clusters and stromal 
cells further stimulates the production of tenascin and 
other invasion-associated molecules that facilitate the 
stromal tissue remodeling and angiogenesis, provid-
ing a favorable micro-environment for epithelial cell 
proliferation  and  migration  [59-60].  Together,  these 
alterations could selectively favor monoclonal prolif-
eration of the overlying tumor progenitors or a bio-
logically more aggressive cell clone. Thus, the inva-
sive and metastatic cells derive from the duct system 
may have greater potential to form tumor nests in the 
new  tissue  sites,  and  consequently  lead  to  worse 
prognosis.  
Implications of our hypothesis 
If  confirmed,  our  hypothesis  would  have  a 
number of clinical implications. First, the application 
of double immunohistochemistry to identify normal 
appearing  lobular  clusters  with  malignan-
cy-associated  alterations  (as  those  shown  in  Fig 
5a-5d), and focal myoepithelial cell layer disruptions 
with “budding” tumor cells (as those shown in Fig 
5e-5h) in clinic biopsies would significantly facilitate 
early  detection  of  individuals  at  greater  risk  to  de-
velop  invasive  cancer  or  pending  invasive  lesions. 
Second, as if  two independent mechanisms or path-
ways are involved for lobular and ductal cancer inva-
sion, the precursors of invasive lesions for these tu-
mors  are  very  likely  to  differ  substantially  in  their 
morphological,  molecular,  and/or  biochemical  pro-
files. As shown in Fig 5a-5d, the entire cell population 
within these morphologically normal appearing lob-
ules  may  directly  progress  to  invasive  lesions  after 
degradation of the associated myoepithelial cell lay-
ers. In sharp contrast, only the cell clusters overlying 
focally disrupted myoepithelial cell layers in the ducts 
(Fig 5e-5h) may progress to invasive cancers through 
monoclonal proliferation of the overlying tumor stem 
cells  or  a  biologically  more  aggressive  cell  clone. 
Consequently,  microdissection  of  these  potential 
precursors  of  invasive  lesions  for  gene  expression 
profiling may lead to identification of more specific 
molecules for differentiation and intervention of in-
vasive lobular and ductal cancer. Third, as it has been 
well  documented  that  invasive  cancer  cells  derived 
from lobular cancer tend to be more ER (+), PR (+), 
and HER-2 (-), compared to their stage-matched duc-
tal counterpart [1-5], invasive and metastatic lesions 
derived  from  these  tumors  may  have  different  re-
sponses to the same therapeutic regimen. Therefore, 
the development of more specific reagents or detec-
tion methods to differentiate lobular and ductal cells Int. J. Biol. Sci. 2011, 7 
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and their malignant derivatives may have significant 
therapeutic value. 
Conclusions 
Based on our own and other studies, we propose 
that the structural and functional difference in their 
surrounding myoepithelial cell layers may represent a 
trigger factor accounting for the substantial difference 
in  clinical  outcomes  between  ILC  and  IDC.  Altera-
tions in the myoepithelial cell layer may directly im-
pact the clinical outcomes of ILC and IDC by control-
ling the genetic property and biological behavior of 
the precursors of invasive lesions, and by dictating the 
lobular  and  ductal  tumors  to  follow  different  path-
ways for invasion and/or metastasis. 
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